Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Ready to talk options
They obtained their metabolic, clinical, and laboratory data at baseline, three, six, nine-, and 12-month follow-ups
7 The trials long-term follow-up periods revealed sustained weight loss with semaglutide treatment, suggesting its potential to maintain reduced body weight over time
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
2009 Jan-Feb;5(1):31-7
US$ 21.61
US$ 29.10
US$ 29.35
US$ 26.97
US$ 26.53
US$ 28.35
US$ 26.48
